{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:21:39Z","timestamp":1791397299206,"version":"4.3.3"},"reference-count":51,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Niemann-Pick type C1 (NP-C1) is a fatal, progressive neurodegenerative disease caused by mutations in the NPC1 gene. Mutations of NPC1 can result in a misfolded protein that is subsequently marked for proteasomal degradation. Such loss-of-function mutations lead to cholesterol accumulation in late endosomes and lysosomes. Pharmacological chaperones (PCs) are described to protect misfolded proteins from proteasomal degradation and are being discussed as a treatment strategy for NP-C1. Here, we used a combinatorial approach of high-throughput in silico screening of FDA-approved drugs and in vitro biochemical assays to identify potential PCs. The effects of the hit compounds identified by molecular docking were compared in vitro with 25-hydroxycholesterol (25-HC), which is known to act as a PC for NP-C1. We analyzed cholesterol accumulation, NPC1 protein content, and lysosomal localization in patient-specific fibroblasts, as well as in neural differentiated and hepatocyte-like cells derived from patient-specific induced pluripotent stem cells (iPSCs). One compound, namely abiraterone acetate, showed comparable results to 25-HC and restored NPC1 protein level, corrected the intracellular localization of NPC1, and consequently decreased cholesterol accumulation in NPC1-mutated fibroblasts and iPSC-derived neural differentiated and hepatocyte-like cells. The discovered PC altered not only the pathophysiological phenotype of cells carrying the I1061T mutation\u2014 known to be responsive to treatment with PCs\u2014but an effect was also observed in cells carrying other NPC1 missense mutations. Therefore, we hypothesize that the PCs studied here may serve as an effective treatment strategy for a large group of NP-C1 patients.<\/jats:p>","DOI":"10.3390\/cells11030319","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T22:46:32Z","timestamp":1642545992000},"page":"319","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems"],"prefix":"10.3390","volume":"11","author":[{"given":"Christin","family":"V\u00f6lkner","sequence":"first","affiliation":[{"name":"Translational Neurodegeneration Section \u201cAlbrecht Kossel\u201d, Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-1999","authenticated-orcid":false,"given":"Supansa","family":"Pantoom","sequence":"additional","affiliation":[{"name":"Translational Neurodegeneration Section \u201cAlbrecht Kossel\u201d, Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Liedtke","sequence":"additional","affiliation":[{"name":"Translational Neurodegeneration Section \u201cAlbrecht Kossel\u201d, Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lukas","sequence":"additional","affiliation":[{"name":"Translational Neurodegeneration Section \u201cAlbrecht Kossel\u201d, Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany"},{"name":"Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, 18147 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-7791","authenticated-orcid":false,"given":"Andreas","family":"Hermann","sequence":"additional","affiliation":[{"name":"Translational Neurodegeneration Section \u201cAlbrecht Kossel\u201d, Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany"},{"name":"Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, 18147 Rostock, Germany"},{"name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen (DZNE) Rostock\/Greifswald, 18147 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-8779","authenticated-orcid":false,"given":"Moritz J.","family":"Frech","sequence":"additional","affiliation":[{"name":"Translational Neurodegeneration Section \u201cAlbrecht Kossel\u201d, Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany"},{"name":"Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, 18147 Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_2","first-page":"166","article-title":"The unique case of the Niemann-Pick type C cholesterol storage disorder","volume":"12","author":"Klein","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science"},{"key":"ref_4","unstructured":"(2021, November 08). The Human Gene Mutation Database. Available online: http:\/\/www.hgmd.org."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: From concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/302626","article-title":"Niemann-Pick C1 disease: The I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype","volume":"65","author":"Millat","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10255","article-title":"Identification of 58 novel mutations in Niemann-Pick disease type C: Correlation with biochemical phenotype and importance of PTC1-like domains in NPC1","volume":"22","author":"Park","year":"2003","journal-title":"Hum. Mutat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1074\/jbc.M708735200","article-title":"Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding","volume":"283","author":"Gelsthorpe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40265-019-01090-4","article-title":"Migalastat: A Review in Fabry Disease","volume":"79","author":"McCafferty","year":"2019","journal-title":"Drugs"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: A comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_12","unstructured":"(2019, January 23). The DrugBank. Available online: https:\/\/go.drugbank.com."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lagorce, D., Sperandio, O., Galons, H., Miteva, M.A., and Villoutreix, B.O. (2008). FAF-Drugs2: Free ADME\/tox filtering tool to assist drug discovery and chemical biology projects. BMC Bioinform., 9.","DOI":"10.1186\/1471-2105-9-396"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"V\u00f6lkner, C., Liedtke, M., Untucht, R., Hermann, A., and Frech, M.J. (2021). Patient-Specific iPSC-Derived Neural Differentiated and Hepatocyte-like Cells, Carrying the Compound Heterozygous Mutation p.V1023Sfs*15\/p.G992R, Present the \u201cVariant\u201d Biochemical Phenotype of Niemann-Pick Type C1 Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212184"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1194\/jlr.M500388-JLR200","article-title":"Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells","volume":"47","author":"Pipalia","year":"2006","journal-title":"J. Lipid Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cell.2009.03.049","article-title":"Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol","volume":"137","author":"Kwon","year":"2009","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/jbiol186","article-title":"What are pharmacological chaperones and why are they interesting?","volume":"8","author":"Ringe","year":"2009","journal-title":"J. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1073\/pnas.1711716114","article-title":"3.3 \u00c5 structure of Niemann-Pick C1 protein reveals insights into the function of the C-terminal luminal domain in cholesterol transport","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.chembiol.2013.02.009","article-title":"Discovery of oxysterol-derived pharmacological chaperones for NPC1: Implication for the existence of second sterol-binding site","volume":"20","author":"Ohgane","year":"2013","journal-title":"Chem. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15388","DOI":"10.1523\/JNEUROSCI.0558-13.2013","article-title":"The Stimulation of Adenosine A 2A Receptors Ameliorates the Pathological Phenotype of Fibroblasts from Niemann-Pick Type C Patients","volume":"33","author":"Visentin","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"24367","DOI":"10.1074\/jbc.M002184200","article-title":"Topological Analysis of Niemann-Pick C1 Protein Reveals That the Membrane Orientation of the Putative Sterol-sensing Domain Is Identical to Those of 3-Hydroxy-3-methylglutaryl-CoA Reductase and Sterol Regulatory Element Binding Protein Cleavage-activating Protein","volume":"275","author":"Davies","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddz215","article-title":"Individualized management of genetic diversity in Niemann-Pick C1 through modulation of the Hsp70 chaperone system","volume":"29","author":"Wang","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zampieri, S., Bembi, B., Rosso, N., Filocamo, M., and Dardis, A. (2012). Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations with MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking. JIMD Reports-Case and Research Reports, 2011\/2, SSIEM and Springer. [1st ed.].","DOI":"10.1007\/8904_2011_49"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Matencio, A., Caldera, F., Cecone, C., L\u00f3pez-Nicol\u00e1s, J.M., and Trotta, F. (2020). Cyclic Oligosaccharides as Active Drugs, an Updated Review. Pharmaceuticals, 13.","DOI":"10.3390\/ph13100281"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1523\/JNEUROSCI.0900-16.2016","article-title":"Reversal of Pathologic Lipid Accumulation in NPC1-Deficient Neurons by Drug-Promoted Release of LAMP1-Coated Lamellar Inclusions","volume":"36","author":"Demais","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: A randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","article-title":"Miglustat in adult and juvenile patients with Niemann\u2013Pick disease type C: Long-term data from a clinical trial","volume":"99","author":"Wraith","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0883073809344222","article-title":"Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C","volume":"25","author":"Patterson","year":"2010","journal-title":"J. Child Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brainres.2016.03.035","article-title":"Lysosome and endoplasmic reticulum quality control pathways in Niemann-Pick type C disease","volume":"1649","author":"Schultz","year":"2016","journal-title":"Brain Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1093\/hmg\/dds145","article-title":"Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts","volume":"21","author":"Yu","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1073\/pnas.1014890108","article-title":"Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts","volume":"108","author":"Pipalia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1194\/jlr.M072140","article-title":"Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells","volume":"58","author":"Pipalia","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"355ra118","DOI":"10.1126\/scitranslmed.aad9823","article-title":"Heat shock protein\u2013based therapy as a potential candidate for treating the sphingolipidoses","volume":"8","author":"Kirkegaard","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jimd.12428","article-title":"Efficacy and safety of arimoclomol in Niemann-Pick disease type C: Results from a double-blind, randomised, placebo-controlled, multinational phase 2\/3 trial of a novel treatment","volume":"44","author":"Mengel","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.bmcl.2014.05.064","article-title":"Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein","volume":"24","author":"Ohgane","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.bmcl.2017.04.062","article-title":"Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 protein","volume":"27","author":"Fukuda","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Shioi, R., Karaki, F., Yoshioka, H., Noguchi-Yachide, T., Ishikawa, M., Dodo, K., Hashimoto, Y., Sodeoka, M., and Ohgane, K. (2020). Image-based screen capturing misfolding status of Niemann-Pick type C1 identifies potential candidates for chaperone drugs. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0243746"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nm.3595","article-title":"Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks","volume":"20","author":"Strittmatter","year":"2014","journal-title":"Nat. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/hmg\/ddy117","article-title":"High-content screen for modifiers of Niemann-Pick type C disease in patient cells","volume":"27","author":"Pugach","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1074\/jbc.M707944200","article-title":"Purified NPC1 protein: II. Localization of sterol binding to a 240-amino acid soluble luminal loop","volume":"283","author":"Infante","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s40265-013-0150-z","article-title":"Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer","volume":"73","author":"Hoy","year":"2013","journal-title":"Drugs"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1074\/mcp.M900314-MCP200","article-title":"Simultaneous Characterization of Glyco- and Phosphoproteomes of Mouse Brain Membrane Proteome with Electrostatic Repulsion Hydrophilic Interaction Chromatography","volume":"9","author":"Zhang","year":"2010","journal-title":"Mol. Cell. Proteom."},{"key":"ref_44","unstructured":"European Medicines Agency (2021, November 08). Assessment Report for Zytiga (Abiraterone) Procedure No.: EMEA\/H\/C\/002321. Available online: https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi02_2rgIn0AhUMi_0HHf4RA_sQFnoECBYQAQ&url=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fdocuments%2Fassessment-report%2Fzytiga-epar-public-assessment-report_en.pdf&usg=AOvVaw0AXzMUSKHIeEs2D9yKYnmC."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The Future of Peptide-based Drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/00016347909154577","article-title":"The Treatment of Postmenopausal Syndrome by Monthly Oral Doses of Quinestrol","volume":"58","author":"Jaschevatzky","year":"1979","journal-title":"Acta Obs. Gynecol. Scand."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Meikle, A.W. (1999). Hormone Replacement Therapy, Humana Press.","DOI":"10.1007\/978-1-59259-700-0"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1038\/s41467-018-06115-2","article-title":"Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD","volume":"9","author":"Schultz","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Liguori, L., Monticelli, M., Allocca, M., Hay Mele, B., Lukas, J., Cubellis, M.V., and Andreotti, G. (2020). Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020489"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tran, M.L., G\u00e9nisson, Y., Ballereau, S., and Dehoux, C. (2020). Second-Generation Pharmacological Chaperones: Beyond Inhibitors. Molecules, 25.","DOI":"10.3390\/molecules25143145"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lopes-Pacheco, M. (2020). CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01662"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/319\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:03:35Z","timestamp":1760133815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cells11030319"],"URL":"https:\/\/doi.org\/10.3390\/cells11030319","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]}}}